The Behavioral Health Landscape

The behavioral health crisis in the United States has created enormous demand for psychiatric services, therapy, and addiction medicine. Wait times for psychiatric appointments are measured in months in many markets. Telehealth has expanded access significantly, but demand still outpaces supply.

For healthcare entrepreneurs, behavioral health represents a compelling business opportunity: strong insurance reimbursement under mental health parity laws, high patient retention, telehealth-friendly services, and significant unmet demand.

The regulatory environment is complex but navigable. Behavioral health practices must comply with HIPAA, DEA regulations (for prescribing), specialized billing rules, and — for substance use disorder treatment — the enhanced confidentiality requirements of 42 CFR Part 2.

Addiction Medicine: MAT Programs

Medication-assisted treatment (MAT) for opioid use disorder is one of the highest-impact services in behavioral health. Buprenorphine (Suboxone, Sublocade) and naltrexone (Vivitrol) are evidence-based, FDA-approved treatments that significantly reduce opioid overdose deaths and improve long-term recovery outcomes.

The X-waiver is gone: As of 2023, the federal requirement for a special DEA waiver to prescribe buprenorphine for OUD was eliminated. Any DEA-registered practitioner with Schedule III prescribing authority can now prescribe buprenorphine for OUD. This has significantly expanded the potential provider pool for MAT.

State requirements: Some states have their own requirements for MAT programs beyond federal law. Verify your state's specific requirements.

42 CFR Part 2: Substance use disorder treatment records are subject to enhanced confidentiality protections. MAT programs must implement 42 CFR Part 2-compliant policies, including specific consent requirements for record disclosure.

Telehealth MAT: Prescribing buprenorphine via telehealth is now permitted under DEA regulations, subject to specific requirements. Verify current DEA telehealth rules before launching a telehealth MAT program.

Behavioral Health Billing

Behavioral health billing has its own CPT code set and billing rules:

Psychiatric evaluation: 90791 (without medical services), 90792 (with medical services)

Psychotherapy: 90832 (30 min), 90834 (45 min), 90837 (60 min) — add-on codes available for combined E&M and therapy

Medication management: 99213-99215 (E&M codes for psychiatric medication management)

Collaborative Care Model: 99492 (initial month), 99493 (subsequent months), 99494 (add-on for additional 30 min)

Mental health parity: Federal law requires commercial insurers and Medicaid to cover mental health services at parity with medical services. Parity violations are a significant source of insurance disputes.

Behavioral health billing companies: Given the complexity of behavioral health billing, many practices use specialized behavioral health billing companies rather than general medical billing services.

Privacy and Compliance: 42 CFR Part 2

Substance use disorder treatment records are subject to 42 CFR Part 2 — a federal regulation that provides stronger privacy protections than standard HIPAA.

What it covers: Any records created in connection with the diagnosis, treatment, or referral for treatment of a substance use disorder at a federally assisted program.

Key restrictions: SUD records cannot be disclosed without specific patient consent in most circumstances — including to other treating providers, law enforcement, and family members. The consent requirements are more specific than standard HIPAA authorizations.

Practical implications: Practices providing SUD treatment must implement 42 CFR Part 2-compliant policies, train staff on the requirements, and use EMR systems that support 42 CFR Part 2 compliance.

Recent changes: The 2024 updates to 42 CFR Part 2 aligned it more closely with HIPAA while maintaining enhanced protections for SUD records. Verify current requirements with a healthcare attorney.